A recent report now indicates that the market for diabetic drugs is poised to grow by almost 120% over the next four years – something that has Big Pharma doing the Happy Dance. Not surprisingly, the U.S., whose completely evil and inhuman profit-driven health care system – controlled by equally inhuman monsters who would gleefully devour their own children if it would raise their corporatations' stock price by even two percent even as they murder 45,000 Americans every year – has been the major source of these profits. (Compare this number to the 3,000 who died on 11 September 2001. What was that about “death panels” again?)
Bryan Helm. who works for the Cape May-Lewes Ferry in Ocean City New Jersey, has his Type-2 diabetes under tight control - the best outcome possible for such patients. First diagnosed over a year ago, Helm began attending classes at a local diabetes center. Here, he was taught what was referred to as the "four aspects of control":
According to a study at Oxford University, patients who undergo knee or hip replacement (arthroplasty), those who use a class of prescription drugs known as bisphosphonates may wind up having fewer revision surgeries.
According to a recent article in the New England Journal of Medicine, two of the four drugs most likely to result in hospitalization among the elderly are those used to treat diabetes.
The risk factors for Type 2 diabetes are well known, but worth reviewing: primarily, these factors are obesity in combination with a sedentary lifestyle, and genetics.
The last issue – genetics – play a larger role among some ethnic groups than others. In fact, people who have Native American ancestry are over twice as like likely to develop Type 2 diabetes than those of European descent, simply because they are Native American. According to a Cherokee Nation newspaper, a whopping 30% of people of American Indian or Inuit extraction are pre-diabetic.
Believe it or not, trace amounts of cobalt is necessary for one's health. This element is a key component in Vitamin B-12. So – why is it that when microscopic bits of cobalt metal from faulty implants get embedded in living tissue, the results include metallosis, synovitis and other health problems?
At the end of September, I reported on a "new" drug from Actos maker Takeda pharmaceutical, which is currently marketed outside the U.S. as Nesina. It is not actually new; it is a combination of Actos and another anti-diabetic drug, alogliptin. which was submitted to the FDA for approval in late 2007, but withdrawn the following year after the FDA determined that additional data was needed.
Hip implant surgery is supposed to relieve pain. In too many cases however, it has the opposite effect – and not simply because they wear out.
The health complications associated with metal-on-metal hip implants is well known and thoroughly documented. What is less well known is the risk of damage to the sciatic nerve, which can leave a patient in excruciating and often untreatable pain.
In September 2011, Chief Judge Garrett Brown of the United States District Court for the District of New Jersey announced his upcoming retirement from the federal bench. Chief Judge Brown was the judge assigned by the Judicial Panel on Multidistrict Litigation ("JPML") to oversee the Fosamax Femur MDL pending in the District of New Jersey. As a result of Judge Brown's announced retirement, the JPML reassigned the Fosamax Femur MDL to District Judge Joel Pisano, effective November 22, 2011. Like Chief Judge Brown, Judge Pisano sits in Trenton, NJ. (
"Corporations are people, my friend." - GOP presidential candidate Mitt Romney
We must give Mr. Romney credit for so openly declaring what most 99% of Americans have long suspected and what the inexcusable Citizens United v. FEC decision made abundantly clear. The question that so many of us have however is that if corporations are people with human rights of free speech, how come they can't be put in jail like natural humans? How come they don't face criminal charges like human felons when they steal and commit murder?
If you are one of the 37,000+ people who have received defective DePuy hip implants and are thinking about joining the rapidly-growing ranks of plaintiffs against this corporation, don't think about it too much longer. Your window of opportunity may be closing soon.
After the Type 2 diabetic drug Actos was linked to an increased risk of bladder cancer last summer, it was pulled off the shelves in France and Germany. (Of course, it remains available in the US, where the large pharmaceutical corporations have bought and paid for legislators and essentially control the FDA – but the agency has at least required a warning label.)
Those who have been worried about the health consequences of metal-on-metal total hip replacements may have an alternative in the form of hip resurfacing, a technique that has been available since 2006. However, evidence shows that while the technique has several advantages over total hip replacement, it results in the same problems.
In its insatiable quest to maximize its profits – even if people have to sicken and die – it seems there is no limit to how far Big Pharma will go.
A study of over 3000 women with polycystic ovary syndrome found an increased risk of adverse pregnancy outcomes such as gestational diabetes, c-section birth, and other issues.
On Friday, October 28, 2011 the Coast Guard Cutter Cypress, which is homeported in Pensacola, Florida, offloaded 7 tons of cocaine at the Coast Guard base in St. Petersburg, Florida. The street value of the cocaine was worth roughly $180 million dollars which is about a third of what law enforcement pulls off the streets in a year in the entire United States. The cocaine came from a single, self-propelled semisubmersible vessel which had been detected and stopped by another Coast Guard Cutter off the coast of Honduras on September 30, 2011.